PRKN and Parkinson disease: Confounding upregulation and downregulation of eCBs and receptors have been observed in individuals with PD and related animal models, including genetically modified mice containing PD-related α-synuclein and Parkin mutations, as well as neurotoxin-induced dopamine depletion in rodents and non-human primates, as extensively reviewed previously[20,28,29].